Priser
Platform
Blog
Om os
Download
Jolt Health
Jolt Health
Canadian Securities Exchange
0

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I JOLT HEALTH MED ENDAVU: Køb Jolt Health ($JOLT) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i Jolt Health, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.

Om

Jolt Health Inc. is a Canadian life sciences company focused on healthcare, biotechnology, and the application of artificial intelligence to therapeutic solutions. Headquartered in Vancouver and founded in 1994, the company operates primarily as a licensee of technologies related to pharmaceutical-grade therapeutics and specialized health products. Jolt Health holds exclusive licenses for a range of innovative therapeutic and pharmaceutical products across Europe, the United Kingdom, and North America.

The company’s portfolio centers on wellness and sexual health formulations, including products that incorporate cannabinoids such as CBD and THC. These are delivered through differentiated dosage forms like oral muco-adhesive strips and orally dissolvable mints, designed to enhance bioavailability, as well as topical gels aimed at localized effects. By combining licensed pharmaceutical technologies, cannabinoid-based formulations, and data-driven approaches, Jolt Health operates at the intersection of life sciences and digital innovation within the broader healthcare and biotechnology markets.

Information

TickerJOLT
Land
Canada
Hjemmesidejolt.health
SektorSundhed
IndustriLægemiddelproducenter - Specialitet og generisk

Udbytter

2.176CAD
'18
Ex-udbytte-dato22. jan. 2018
Udbytteafkast0%